PUBLISHER: Value Market Research | PRODUCT CODE: 2064224
PUBLISHER: Value Market Research | PRODUCT CODE: 2064224
Global Geographic Atrophy Market Size, Share, Trends & Growth Analysis Report 2026-2034
The global geographic atrophy market size is expected to reach USD 8.65 Billion in 2034 from USD 2.69 Billion in 2025, growing at a CAGR of 13.87 during 2026-2034.This market is gaining momentum due to the increasing prevalence of age-related macular degeneration, particularly among the growing elderly population. Geographic atrophy represents an advanced form of retinal degeneration that can lead to severe vision loss, creating significant demand for effective treatments and disease management solutions. Advancements in diagnostic technologies and improved awareness among healthcare professionals are contributing to earlier detection and increased treatment adoption.
Key growth drivers include rising healthcare expenditures, expanding research activities, and growing investments in ophthalmology-focused drug development. Pharmaceutical companies are actively developing novel therapies aimed at slowing disease progression and preserving vision. Improved access to healthcare services and enhanced screening programs are also supporting market growth. Furthermore, advancements in retinal imaging technologies enable more accurate diagnosis and monitoring, helping physicians deliver better patient outcomes.
The future of the geographic atrophy market appears promising as innovative therapies continue to emerge from clinical research pipelines. Increasing collaborations between biotechnology firms, pharmaceutical companies, and research institutions are expected to accelerate treatment development. Personalized medicine approaches and advanced diagnostic tools may further improve disease management. With aging populations increasing worldwide and awareness of vision-related disorders growing, the market is expected to experience sustained expansion over the coming years.
Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:
Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.
Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.
Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.
Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.
Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.
Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.
Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.
Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.
MARKET SEGMENTATION
By Drug Type
- Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
- Complement Inhibitors
- Neuroprotective Agents
- Other Drugs
By Diagnosis
- Fundus Autofluorescence (FAF)
- Optical Coherence Tomography Angiography (OCT-A)
- Multifocal Electroretinography (MFERG)
By Route Of Administration
- Intravitreal
- Oral
- Other Routes Of Administration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
COMPANIES PROFILED
- Regeneron Pharmaceuticals Inc., Boehringer Ingelheim, Astellas Pharma Inc., Biogen Inc., Ocugen Inc., Kodiak Sciences Inc., Apellis Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Voyager Therapeutics, Kriya Therapeutics, Stealth BioTherapeutics, Kiora Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Nanoscope Therapeutics
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL GEOGRAPHIC ATROPHY MARKET: BY DRUG TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Drug Type
- 4.2. Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Complement Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Neuroprotective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Other Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL GEOGRAPHIC ATROPHY MARKET: BY DIAGNOSIS 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Diagnosis
- 5.2. Fundus Autofluorescence (FAF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Optical Coherence Tomography Angiography (OCT-A) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Multifocal Electroretinography (MFERG) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL GEOGRAPHIC ATROPHY MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Route Of Administration
- 6.2. Intravitreal Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Other Routes Of Administration Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL GEOGRAPHIC ATROPHY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Distribution Channel
- 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL GEOGRAPHIC ATROPHY MARKET: BY REGION 2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Drug Type
- 8.2.2 By Diagnosis
- 8.2.3 By Route Of Administration
- 8.2.4 By Distribution Channel
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Drug Type
- 8.3.2 By Diagnosis
- 8.3.3 By Route Of Administration
- 8.3.4 By Distribution Channel
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Drug Type
- 8.4.2 By Diagnosis
- 8.4.3 By Route Of Administration
- 8.4.4 By Distribution Channel
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Drug Type
- 8.5.2 By Diagnosis
- 8.5.3 By Route Of Administration
- 8.5.4 By Distribution Channel
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Drug Type
- 8.6.2 By Diagnosis
- 8.6.3 By Route Of Administration
- 8.6.4 By Distribution Channel
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL GEOGRAPHIC ATROPHY INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Regeneron Pharmaceuticals Inc
- 10.2.2 Boehringer Ingelheim
- 10.2.3 Astellas Pharma Inc
- 10.2.4 Biogen Inc
- 10.2.5 Ocugen Inc
- 10.2.6 Kodiak Sciences Inc
- 10.2.7 Apellis Pharmaceuticals Inc
- 10.2.8 NGM Biopharmaceuticals Inc
- 10.2.9 Voyager Therapeutics
- 10.2.10 Kriya Therapeutics
- 10.2.11 Stealth BioTherapeutics
- 10.2.12 Kiora Pharmaceuticals
- 10.2.13 Iveric Bio
- 10.2.14 Alkeus Pharmaceuticals
- 10.2.15 Nanoscope Therapeutics
